SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-036753
Filing Date
2011-02-15
Accepted
2011-02-15 16:11:13
Documents
13
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20F d20f.htm 20-F 2605549
2 3-YEAR SENIOR UNSECURED REVOLVING CREDIT AGREEMENT DATED AS OF JANUARY 20, 2011 dex217.htm EX-2.17 703621
3 SUBSIDIARIES OF THE REGISTRANT dex8.htm EX-8 15883
4 CONSENT OF KESSELMAN & KESSELMAN dex10.htm EX-10 2521
5 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex12i.htm EX-12.(I) 9465
6 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex12ii.htm EX-12.(II) 9563
7 CERTIFICATION OF THE CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex13.htm EX-13 4605
  Complete submission text file 0001193125-11-036753.txt   19911970

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT teva-20101231.xml EX-101.INS 2683623
9 XBRL TAXONOMY EXTENSION SCHEMA teva-20101231.xsd EX-101.SCH 155616
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20101231_cal.xml EX-101.CAL 148399
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20101231_def.xml EX-101.DEF 456120
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20101231_lab.xml EX-101.LAB 1188298
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20101231_pre.xml EX-101.PRE 793308
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-16174 | Film No.: 11614368
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1